Australia's Anatara Lifesciences hits 1-month high on patent grant

Anatara Lifesciences

20/09/2024 05:13

** Shares of Anatara Lifesciences  ANR.AX  rise as much as
8.7% to A$0.05, their highest since Aug. 22
    ** Stock marks biggest intraday pct gain since Sept. 11
    ** Gastrointestinal health products maker says granted
European patent for Gastrointestinal ReProgramming product(GaRP)
    ** Co says patent is being validated in 19 major European
countries and the UK until March 2039
    ** Stock has more than doubled in value YTD as of 0350 GMT,
vs the ASX 200 benchmark  .AXJO , which rose 8.3%

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))